| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
20,416 |
14,363 |
$2.10M |
| H2020 |
Therapeutic behavioral services, per diem |
2,772 |
1,112 |
$198K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,062 |
4,085 |
$46K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,463 |
6,803 |
$8K |
| D0999 |
Unspecified diagnostic procedure, by report |
131 |
105 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,460 |
1,231 |
$2K |
| 90674 |
|
87 |
82 |
$1K |
| 0002A |
|
93 |
49 |
$310.40 |
| 0011A |
|
185 |
86 |
$99.16 |
| 0012A |
|
331 |
138 |
$62.08 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,924 |
2,751 |
$44.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
425 |
298 |
$23.35 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
436 |
361 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,135 |
914 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
418 |
298 |
$0.00 |
| 86361 |
|
814 |
643 |
$0.00 |
| 86592 |
|
346 |
263 |
$0.00 |
| 90686 |
|
752 |
635 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,998 |
1,474 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
44 |
38 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,016 |
819 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
539 |
419 |
$0.00 |
| 87536 |
|
933 |
726 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
153 |
127 |
$0.00 |
| 87511 |
|
92 |
76 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
186 |
133 |
$0.00 |
| 91301 |
|
621 |
260 |
$0.00 |
| 86780 |
|
35 |
25 |
$0.00 |
| 86706 |
|
30 |
26 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
260 |
83 |
$0.00 |
| 87529 |
|
50 |
41 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
86 |
74 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
74 |
51 |
$0.00 |
| 90656 |
|
65 |
43 |
$0.00 |
| 84703 |
|
16 |
14 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
13 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
72 |
66 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
14 |
$0.00 |
| 86803 |
|
74 |
51 |
$0.00 |
| 86704 |
|
13 |
12 |
$0.00 |
| 3017F |
|
13 |
12 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
136 |
118 |
$0.00 |
| 1036F |
|
30 |
20 |
$0.00 |
| 0001A |
|
19 |
16 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
13 |
$0.00 |
| 87340 |
|
13 |
12 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
43 |
34 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
13 |
12 |
$0.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
46 |
40 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
714 |
579 |
$0.00 |
| 80074 |
|
156 |
111 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
420 |
331 |
$0.00 |
| 81003 |
|
804 |
641 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
545 |
421 |
$0.00 |
| 80061 |
Lipid panel |
259 |
205 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
44 |
26 |
$0.00 |
| 99201 |
|
46 |
34 |
$0.00 |
| 91300 |
|
95 |
59 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,014 |
434 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
57 |
44 |
$0.00 |
| 87481 |
|
92 |
76 |
$0.00 |
| 86480 |
|
142 |
99 |
$0.00 |
| 90611 |
|
92 |
69 |
$0.00 |
| D0330 |
Panoramic radiographic image |
45 |
41 |
$0.00 |
| 84403 |
|
31 |
27 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
84 |
74 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
85 |
53 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
56 |
44 |
$0.00 |
| 81025 |
|
29 |
24 |
$0.00 |
| 86708 |
|
23 |
14 |
$0.00 |
| 99497 |
|
84 |
78 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$0.00 |